Literature DB >> 2010425

Treatment of status asthmaticus with intravenous magnesium sulfate.

H Okayama1, M Okayama, T Aikawa, M Sasaki, T Takishima.   

Abstract

The bronchodilating effect of magnesium sulfate (MgSO4) was studied in two patients with status asthmaticus, who were intubated and mechanically ventilated by a respirator. Airway resistance was continuously monitored by the respiration-controlled interruption technique. After administration of 0.5 mmol/min MgSO4 intravenously, airway resistance decreased from 17 to 9, and from 13 to 8 mmHg/L/s in the two patients, respectively, and piping rales diminished or disappeared. We conclude that while corticosteroid therapy requires several hours to demonstrate significant effects in status asthmaticus, MgSO4 is of great benefit in the rapid improvement of airflow obstruction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010425     DOI: 10.3109/02770909109073366

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  2 in total

1.  High-dose intravenous magnesium sulfate in the management of life-threatening status asthmaticus.

Authors:  M Sydow; T A Crozier; S Zielmann; J Radke; H Burchardi
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

2.  The efficacy of nebulized magnesium sulfate alone and in combination with salbutamol in acute asthma.

Authors:  Hatem A Sarhan; Omar H El-Garhy; Mohamed A Ali; Nouran A Youssef
Journal:  Drug Des Devel Ther       Date:  2016-06-09       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.